Research
Recent grants/funding applications
2023-2028 (5 years) Liverpool: Mental Health Research for Innovation Centre (M-RIC) NIHR/OLS £10,477,054 [Co-applicant]
2022-2024 (3 years) DynAIRx: AIs for dynamic prescribing optimisation and care integration in multimorbidity. NIHR-AIM NIHR203986). £2,807,430 [Co-applicant]
2022-2025 (4 years) LJMU Thematic Doctoral Training Programme with MITH. £431,616 [Co-applicant/advisor]
Cardiovascular pathology, ageing, and frailty.
Favourite talk:
2019 Late Breaking Science in Heart Failure Session, European Society of Cardiology Congress, Paris. ‘Spironolactone in atrial fibrillation with preserved cardiac contractility’
Invited talks:
2018 ‘The role of circulating monocytes in atherosclerosis’ at Frontiers in CardioVascular Biology Congress, 20-22/09/2018, Vienna
2017 ‘Monocyte subsets in cardiac disease and repair’ at Meeting of the Federation of European Physiological Societies (FEPS) 13-15/09/2017, Vienna
2015 ‘South Asians with Heart Failure: Vascular Function and Coronary Disease’ 2015 Annual Scientific Meeting Sept 26-29, Washington DC (online presentation)
2013 'Microparticles and cardiovascular disease’ at “Microparticles as regulators and indicators of cardiovascular and metabolic disease” A Society for Endocrinology Workshop, London
2011 ‘Monocytes and cardiovascular repair’. Conference: The Leukocyte In Cardiovascular Disease, Geneva
2010 ‘Aspirin resistance: reality of myth?’. 7th European Angiology Days. Milan, Italy
Research Funding:
2014-2018 ‘IMPRESS-AF: IMproved exercise tolerance in heart failure with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation’ NIHR-EME Programme. £779,083 [Grant Co-Primary Investigator, Trial Primary Investigator]
2015 ‘Effect of aldosterone inhibition on cardiac and systemic fibrosis in atrial fibrillation. European Society of Cardiology (ESC) Fellowship for Dr M. Dzeshka. €25000 [Co-supervisor]
2013 ‘Pathophysiological and prognostic significance of circulating microparticles, left ventricular fibrosis and diastolic dysfunction in atrial fibrillation. European Heart Rhythm Association Fellowship for Dr M. Dzeshka. €50000 [Co-supervisor]
2011 ‘Fibrinolytic activity in acute coronary syndrome, implication of monocytes’. ECS Atherothrombosis Research Fellowship for Dr S. Apostolakis. €50000 [Co-supervisor]
2010 ‘Variability of Responsiveness to Antiplatelet Therapy with Aspirin and Clopidogrel in Patients with Coronary Artery Disease: Relationships to Endothelial Dysfunction, Inflammation and the Prothrombotic state.’ ESC Atherothrombosis Research Fellowship for Dr N. Kuzniatsova. €50000 [Co-supervisor]
2010 ‘Monocyte functional subpopulations in patients with acute coronary syndromes and their relation to markers of inflammation and vascular damage.’ ESC Atherothrombosis Research Fellowship for Dr B. Pamukçu. €50000 [Co-supervisor]
Awards:
2018 'Highly commended', BMA Medical Book Awards 2018 in the Primary health care nomination: ‘Textbook of Occupational Medicine Practice’, 4th Edition, World Scientific Publishing. Author of the cardiology section
2016 CRN West Midlands Clinical Research Impact 'Award 2016 to SWBH Atrial Fibrillation Research Team'
2016 Sandwell and West Birmingham Hospitals Star Awards Excellence in Research Prize as a Member of Atrial Fibrillation Research Team'
Fellowships:
2008 (2 years) Research fellowship by the Heart Failure Association of the European Society of Cardiology. ‘Ethnic differences in endothelial function in patients with heart failure
2006 (6 months) Clinical Training Fellowship of the European Society of Cardiology. ‘Endothelial progenitor cells and circulating endothelial cells in patients with atrial fibrillation’
2009 ’A study of monocyte functional subpopulations in patients with acute coronary syndromes.’ Project grant by Heart Research UK. £47,862. [Applicant]
Research grants
Mental Health Research for Innovation Centre (M-RIC)
DEPARTMENT OF HEALTH & SOCIAL CARE (UK)
January 2023 - December 2027